Field Orthopaedic Plating System - Orthopaedic fixation plate kit, non-biodegradable Australie - anglais - Department of Health (Therapeutic Goods Administration)

field orthopaedic plating system - orthopaedic fixation plate kit, non-biodegradable

field orthopaedics pty ltd - 46649 - orthopaedic fixation plate kit, non-biodegradable - the field orthopaedics plate and screws are intended for use in the fixation of fractures, osteotomies and arthrodesis

Wart-removal dressing Australie - anglais - Department of Health (Therapeutic Goods Administration)

wart-removal dressing

pharmacare laboratories pty ltd - 48019 - wart-removal material - dual action. can help to: -counteract the viruses that cause warts*. -reduce the chance of re-infection**. wart-off cream can be used for all types of warts except genital warts. wart-off cream can be used for: -common warts.-plantar warts. -flat warts. -filiform warts.-water warts. dual action: -*tea tree oil can help to counteract viruses and limit virus expansion with its antiviral properties. -**the dimethicone in wart-off cream can help to form a protective film over the wart and this may reduce the chances of re-infection. it may also make the skin soft, elastic and also has a waterproof function. the urea in wart-off cream is a moisturiser, which can loosen hard skin and may assist the disappearance of warts. a compound of substances (e.g., urea) and plant extract oils (e.g., tea tree, lavender, geranium) in the form of an ointment that is topically applied onto the surface of a wart and surrounding skin of the user, protecting the skin from further infection, and after repeated applications, the wart will become necrotic and fall off. it is typically contained in a small container that may be carried upon the user for convenient access. it is normally available.

FLOREXA- eflornithine hydrochloride cream États-Unis - anglais - NLM (National Library of Medicine)

florexa- eflornithine hydrochloride cream

pella pharmaceuticals co. ltd - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - florexa is indicated for the reduction of unwanted facial hair in women. florexa has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. eflomithine hcl is contraindicated in patients with a history of sensitivity to any components of the preparation. children less than 12 years of age shouldn't use florexa .

Tubing extension set, intravenous administration Australie - anglais - Department of Health (Therapeutic Goods Administration)

tubing extension set, intravenous administration

becton dickinson pty ltd - 12170 - tubing extension set, intravenous administration - for the general purpose of supplying the circulatory system with fluids and are generally used when the required volume or duration of fluid administration make conventional injection methods (e.g., manual administration by clinician using a syringe) impractical and/or contraindicated.

Peripheral vascular infusion/aspiration catheter Australie - anglais - Department of Health (Therapeutic Goods Administration)

peripheral vascular infusion/aspiration catheter

becton dickinson pty ltd - 40601 - peripheral vascular infusion/aspiration catheter - used to gain access to peripheral veins of the patient's blood stream for rehydration, parenteral nutrition, medication delivery, blood transfusion and monitoring purposes

DEMECAN 16:01 FLORESTURA Australie - anglais - Department of Health (Therapeutic Goods Administration)

demecan 16:01 florestura

little green pharma ltd - tetrahydrocannabinol, quantity: 0.16 g/g; cannabidiol, quantity: 0.01 g/g - herb, dried - excipient ingredients: air - there is growing evidence that medicinal cannabis may have a role in several medical conditions. these include intractable chronic pain insufficiently responsive to other analgesics, pain associated with spasticity in multiple sclerosis (ms), pain associated with cancer in palliative care, nausea and vomiting caused by cancer treatment, appetite loss, sleep disturbance, post-traumatic stress disorder (ptsd), body wasting. your doctor may have prescribed lgp medicinal cannabis dried flower for another reason.

DEMECAN 18:01 FLORESTURA Australie - anglais - Department of Health (Therapeutic Goods Administration)

demecan 18:01 florestura

little green pharma ltd - tetrahydrocannabinol, quantity: 0.18 g/g; cannabidiol, quantity: 0.01 g/g - herb, dried - excipient ingredients: air - there is growing evidence that medicinal cannabis may have a role in several medical conditions. these include intractable chronic pain insufficiently responsive to other analgesics, pain associated with spasticity in multiple sclerosis (ms), pain associated with cancer in palliative care, nausea and vomiting caused by cancer treatment, appetite loss, sleep disturbance, post-traumatic stress disorder (ptsd), body wasting. your doctor may have prescribed lgp medicinal cannabis dried flower for another reason.

DEMECAN 20:01 FLORESTURA Australie - anglais - Department of Health (Therapeutic Goods Administration)

demecan 20:01 florestura

little green pharma ltd - tetrahydrocannabinol, quantity: 0.2 g/g; cannabidiol, quantity: 0.01 g/g - herb, dried - excipient ingredients: air - there is growing evidence that medicinal cannabis may have a role in several medical conditions. these include intractable chronic pain insufficiently responsive to other analgesics, pain associated with spasticity in multiple sclerosis (ms), pain associated with cancer in palliative care, nausea and vomiting caused by cancer treatment, appetite loss, sleep disturbance, post-traumatic stress disorder (ptsd), body wasting. your doctor may have prescribed lgp medicinal cannabis dried flower for another reason.

DEMECAN 22:01 FLORESTURA Australie - anglais - Department of Health (Therapeutic Goods Administration)

demecan 22:01 florestura

little green pharma ltd - tetrahydrocannabinol, quantity: 0.22 g/g; cannabidiol, quantity: 0.01 g/g - herb, dried - excipient ingredients: air - there is growing evidence that medicinal cannabis may have a role in several medical conditions. these include intractable chronic pain insufficiently responsive to other analgesics, pain associated with spasticity in multiple sclerosis (ms), pain associated with cancer in palliative care, nausea and vomiting caused by cancer treatment, appetite loss, sleep disturbance, post-traumatic stress disorder (ptsd), body wasting. your doctor may have prescribed lgp medicinal cannabis dried flower for another reason.

DEMECAN 24:01 FLORESTURA Australie - anglais - Department of Health (Therapeutic Goods Administration)

demecan 24:01 florestura

little green pharma ltd - tetrahydrocannabinol, quantity: 0.24 g/g; cannabidiol, quantity: 0.01 g/g - herb, dried - excipient ingredients: air - there is growing evidence that medicinal cannabis may have a role in several medical conditions. these include intractable chronic pain insufficiently responsive to other analgesics, pain associated with spasticity in multiple sclerosis (ms), pain associated with cancer in palliative care, nausea and vomiting caused by cancer treatment, appetite loss, sleep disturbance, post-traumatic stress disorder (ptsd), body wasting. your doctor may have prescribed lgp medicinal cannabis dried flower for another reason.